Efficacy of sorafenib in patients with hepatocellular carcinoma after resection: a meta-analysis

BACKGROUND: The prognosis of hepatocellular carcinoma remains poor even after curative resection and it has no effective adjuvant therapy. AIM: This meta-analysis aimed to assess efficacy of sorafenib as adjuvant therapy for patients with hepatocellular carcinoma after resection. MATERIALS AND METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Jin, Xu, Shanling, Zhang, Jiaxing, Ran, Xuting, Bai, Lang, Tang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752555/
https://www.ncbi.nlm.nih.gov/pubmed/29312642
http://dx.doi.org/10.18632/oncotarget.21299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752555/
https://www.ncbi.nlm.nih.gov/pubmed/29312642
http://dx.doi.org/10.18632/oncotarget.21299

Ejemplares similares